Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2016 / Sep / Heidelberg Engineering receives FDA clearance to market SPECTRALIS® OCT Glaucoma Module Premium Edition
Glaucoma Glaucoma

Heidelberg Engineering receives FDA clearance to market SPECTRALIS® OCT Glaucoma Module Premium Edition

9/26/2016 1 min read

Share

The Glaucoma Module Premium Edition for SPECTRALIS provides a comprehensive analysis of the optic nerve head, retinal nerve fiber layer, and ganglion cell layer by precisely matching unique scan patterns to the fine anatomic structures relevant in glaucoma diagnostics. By means of a new proprietary technology called the Anatomic Positioning System, the module creates an anatomic map unique to each patient’s eye using two fixed, structural landmarks: the center of the fovea and the center of Bruch’s membrane opening. All subsequent scan protocols are automatically oriented according to each eye’s unique anatomic map, enabling a precise examination of relevant structures over time. Furthermore, the Glaucoma Module Premium Edition compares patients’ eyes to an age- and disc size-adjusted reference database of healthy eyes representing the racial and ethnic mix of the US population, flagging small deviations that may be clinically relevant. This allows for a highly sensitive assessment of structural damage characteristic of glaucoma and a close monitoring of structural changes indicative of glaucomatous progression. The physiological and technical premise of the Glaucoma Module Premium Edition is based on research collaborations between two groups led by Balwantray C. Chauhan, Ph.D., Dalhousie University in Halifax (Canada), and Claude F. Burgoyne, M.D., Devers Eye Institute in Portland, OR (USA) performed with the SPECTRALIS imaging platform1,2,3,4,5,6. Their work revealed the importance of making an anatomically and geometrically accurate neuroretinal rim measurement using Bruch’s membrane opening, the anatomical outer border of the rim. “The measurements are more accurate because they are based on an identifiable anatomical border of the rim and take into account its varying geometry at the point of measurement”, said Dr. Burgoyne. Dr. Chauhan added: “We have already been able to demonstrate that the use of this new measurement method translates into significantly enhanced diagnostic accuracy.” “The 510(k) clearance of this product is great news for our company and also for glaucoma patients in the U.S.  The Glaucoma Module Premium Edition is an excellent tool to assess glaucomatous damage based on a novel objective examination of the optic nerve head anatomy”, summarizes Dr. Gerhard Zinser, Managing Director of Heidelberg Engineering. References:

  1. Chauhan B.C. et al., Ophthalmology, 2013;120:535–543.
  2. Chauhan B.C. and Burgoyne C.F., Am J Ophthalmol. 2013;156:218-227.
  3. Chauhan B.C. et al.,Ophthalmology, 2015;122:1786-1794.
  4. He L. et al., PLoS One, 2014;9:e92225.
  5. Reis A.S.et al., Ophthalmology, 2012;119:738–747.
  6. Reis A.S. et al., Invest. Ophthalmol. Vis. Sci., 2012;53:1852–1860.

Heidelberg Engineering www.HeidelbergEngineering.com

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: